Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
aging
Biotech
BioAge secures Novartis deal worth up to $550M biobucks
The Novartis deal comes less than two weeks after BioAge discarded a phase 2 obesity trial and less than three months after its Nasdaq debut.
Gabrielle Masson
Dec 18, 2024 10:44am
RANKL cytokine makes the thymus more youthful in mice
Dec 5, 2024 11:45am
Advantage spins out anti-aging R&D to new biotech Klothea
Nov 25, 2024 11:56am
CAR-T cells prevent and reverse signs of metabolic age in mice
Jan 30, 2024 10:24am
Bayer inks two consumer health collabs around healthy aging
Dec 7, 2023 12:56pm
AgeX keeps defying time to survive multiyear cash crunch
Aug 15, 2023 7:00am
